The impact of tibolone and hormone therapy on serum C-reactive protein, tumor necrosis factor-alpha and hepatocyte growth factor in postmenopausal women

scientific article

The impact of tibolone and hormone therapy on serum C-reactive protein, tumor necrosis factor-alpha and hepatocyte growth factor in postmenopausal women is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/13697130802479580
P698PubMed publication ID19012050

P2093author name stringM Erenus
K Sezer Ozer
T Yoldemir
P2860cites workRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trialQ27860743
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research GroupQ29615228
C-reactive protein, inflammation, and coronary riskQ33843636
Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up StudyQ34184063
Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failureQ40510836
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American womenQ40608305
Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatmentQ40769278
Inflammation in ischaemic heart diseaseQ43187895
Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal womenQ43758821
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) StudyQ43788768
The in vivo human metabolism of tiboloneQ43855683
Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogenQ43933082
A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal womenQ43992057
Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal womenQ44150997
Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trialQ44155838
The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trialQ44205516
Effect of tibolone treatment on intima-media thickness and the resistive indices of the carotid arteriesQ44303599
Hormone replacement therapy causes a decrease in hepatocyte growth factor in hypertensive womenQ44460526
Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover studyQ46472616
P433issue1
P304page(s)66-71
P577publication date2009-02-01
P1433published inClimactericQ5133381
P1476titleThe impact of tibolone and hormone therapy on serum C-reactive protein, tumor necrosis factor-alpha and hepatocyte growth factor in postmenopausal women
P478volume12

Reverse relations

cites work (P2860)
Q89993571Cardiovascular Risk/Benefit Profile of MHT
Q45152775Distribution and determinants of C-reactive protein in the older adult population: European Prospective Investigation into Cancer-Norfolk study
Q44518503Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study
Q37768413Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials

Search more.